Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 18, 2026 05:39 ET | Source: Research and Markets

Nanotechnology in Drug Delivery Business Research Report 2026-2032: Market to Reach $161 Billion - Patent Expirations of Blockbuster Drugs Puts Spotlight on Nanodelivery as a Differentiation Strategy

Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Nanotechnology in Drug Delivery - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...
May 15, 2026 04:23 ET | Source: Research and Markets

CNM-Au8 Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "CNM-Au8 Sales Forecast and Market Size Analysis - 2034" has been added to ResearchAndMarkets.com's offering.The report encompasses CNM-Au8's MoA,...
May 15, 2026 04:21 ET | Source: Research and Markets

Dementia Associated With Alzheimer's Disease Market Research Report 2026: Overview of Over 80 Companies and More Than 100 Pipeline Drugs

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Dementia Associated With Alzheimer'S Disease - Pipeline Insight, 2026" has been added to ResearchAndMarkets.com's offering. The report provides a...
March 04, 2026 06:59 ET | Source: Research and Markets

$80+ Bn Drug Delivery Systems Markets - Global Forecast 2026-2032

Dublin, March 04, 2026 (GLOBE NEWSWIRE) -- The "Drug Delivery Systems Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The global drug delivery...
January 26, 2026 04:07 ET | Source: Research and Markets

Central Nervous System Therapeutics Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Central Nervous System Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
October 22, 2025 04:50 ET | Source: Research and Markets

Image-Guided Drug Delivery Research and Forecast Report 2025-2035: AI-Assisted Infusion Planning, MRI-Compatible Robotics, and Multimodal Imaging Innovations Fuel Expansion

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Image-Guided Drug Delivery Market - A Global and Regional Analysis: Focus on Technology Type, Application, End User, and Regional Analysis - Analysis...
September 10, 2025 10:00 ET | Source: NanoNewron

NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program

NanoNewron awarded a $2.5 million NIH grant to develop TNF-α inhibitors engineered to cross the Blood-Brain Barrier to treat Alzheimer’s disease
June 16, 2025 11:16 ET | Source: Research and Markets

Opportunities in the Central Nervous System (CNS) Therapeutics Market: Revenues Forecast to Reach US$156.5 Billion by 2030

Dublin, June 16, 2025 (GLOBE NEWSWIRE) -- The "Central Nervous System Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...
May 28, 2025 09:36 ET | Source: Research and Markets

Targeted Drug Delivery Research Business Analysis Report 2024-2030 with Focus on 30+ Key Players Such as AbbVie, Amgen, AstraZeneca, Becton Dickinson and Co, & Bristol-Myers Squibb

Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Targeted Drug Delivery - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Targeted...
March 04, 2025 15:13 ET | Source: NanoNewron

NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the Company and the Development of Their Promising Alzheimer’s Compound

Marco Taglietti, MD is appointed CEO of NanoNewron, a company developing TNF-α inhibitors for Alzheimer’s, engineered to cross the Blood-Brain Barrier